Branford, CT, United States of America

Jeffrey Johnson

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Bayer Corporation, Bayer Healthcare LLC, Bayer Intellectual Property Gmbh. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Johnson. Retrieved from https://idiyas.com/inventor/jeffrey-johnson-2aji2yoo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0


Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 100(Granted Patents)


Location History:

  • Branford, CT (US) (2002 - 2009)
  • North Branford, CT (US) (2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Johnson

Introduction

Jeffrey Johnson is a notable inventor based in Branford, CT (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 4 patents, he has made strides in developing novel compounds aimed at treating various medical conditions.

Latest Patents

Among his latest patents, Johnson has developed sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives, which are useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. This invention focuses on novel sulfone 2I3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing these compounds, and their application in phosphatidylinositol-3-kinase (PI3K) inhibition. This work is particularly relevant for treating hyper-proliferative and/or angiogenesis-mediated disorders, either as a sole agent or in combination with other active ingredients. Additionally, he has explored methods for inhibiting RAF kinase using aryl and heteroaryl substituted heterocyclic ureas, which are aimed at treating tumors mediated by RAF kinase.

Career Highlights

Throughout his career, Johnson has worked with prominent companies such as Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Johnson has collaborated with notable colleagues, including William Johnston Scott and Jill E Wood, enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Jeffrey Johnson's innovative work in the pharmaceutical industry showcases his dedication to advancing medical treatments through his patented inventions. His contributions continue to influence the field and offer hope for addressing complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…